Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age. (8th October 2021)

• Record Type: Journal Article
• Authors: Pastuszak, Alexander W.; Gittelman, Marc; Tursi, James P.; Jaffe, Jonathan S.; Schofield, David; Miner, Martin M.
• Is Part Of: Andrology. Volume 10:Number 2(2022)
• Page Start: 209
• Page End: 222
• Publication Date: 2021-10-08
• Subjects: diurnal variation -- testosterone deficiency -- testosterone therapy; Andrology -- Periodicals; 616.65
• DOI: 10.1111/andr.13108
• Languages: English
• ISSNs: 2047-2919

Abstract

Abstract: Background: To improve symptoms associated with testosterone deficiency, many testosterone therapies are available that aim to restore serum testosterone (T) levels to the normal physiologic range. The magnitude, frequency, and duration between peak and trough T concentrations vary with route of administration, and none reflect normal endogenous daily diurnal T variations. Objective: To compare pharmacokinetic profiles of serum T from approved T formulations with endogenous diurnal T variations in young and older men, and to consider whether there may be value in mimicking the diurnal T rhythmicity with exogenous testosterone therapies as men age. Materials and methods: A literature search of studies examining the diurnal variation of endogenous T in healthy men and men with testosterone deficiency was performed using PubMed in January 2020. Additional searches for serum T pharmacokinetic profiles of various testosterone therapy formulations were also conducted. Prescribing information for various T formulations was also reviewed. Discussion and conclusion: Endogenous diurnal T variation is well described and appears to be blunted naturally as men age. Men with testosterone deficiency lack diurnal T variation and exhibit a flatter T profile compared with eugonadal men. Some T replacement options provide intraday T level variations similar to normal circadian secretion, and others provide a flatter exposure profile reflective of depot release. Others provide profiles that exceed the frequency and physiologic range of the natural diurnal variation of T. All exogenous T replacement dosing targets an increase in average T levels to within the normal physiologic range and improves symptoms associated with low T, but no single testosterone therapy can exactly mimic the normal diurnal T patterns seen in younger men and the blunted circadian T secretion of older men.